Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Piotr Szczudlik
Sign up to set email alerts
34
Publications
1,509
Citation Statements Received
895
Citation Statements Given
How they've been cited
1,699
106
1,381
22
How they cite others
762
122
717
56
Affiliations
Medical University of Warsaw
,
Medical University of Lublin
Publications
Order By: Most citations
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
Howard
1
,
Bril
2
,
Vu
3
et al.
2021
The Lancet Neurology
750
45
553
3
3
Get access via publisher
Add to collection
Cite
A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis
Zisimopoulou
1
,
Evangelakou
2
,
Tzartos
3
et al.
2014
Journal of Autoimmunity
Abstract
Show
336
16
331
4
Get access via publisher
Add to collection
Cite
Genome-Wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of TNFRSF11A and Identification of ZBTB10 and Three Distinct HLA Associations
Seldin
1
,
Alkhairy
2
,
Lee
3
et al.
2015
Mol Med
79
9
79
1
Get access via publisher
Add to collection
Cite
MuSK autoantibodies in myasthenia gravis detected by cell based assay — A multinational study
Tsonis
1
,
Zisimopoulou
2
,
Lazaridis
3
et al.
2015
Journal of Neuroimmunology
Abstract
Show
82
3
72
2
Get access via publisher
Add to collection
Cite
Titin antibodies in “seronegative” myasthenia gravis — A new role for an old antigen
Stergiou
1
,
Lazaridis
2
,
Zouvelou
3
et al.
2016
Journal of Neuroimmunology
76
7
64
0
Get access via publisher
Add to collection
Cite
Determinants of Quality of Life in Myasthenia Gravis Patients
Szczudlik
1
,
Sobieszczuk
2
,
Szyluk
3
et al.
2020
Front. Neurol.
Abstract
Show
59
10
51
4
Get access via publisher
Add to collection
Cite
Antititin antibody in early- and late-onset myasthenia gravis
Szczudlik
1
,
Szyluk
2
,
Lipowska
3
et al.
2014
Acta Neurol Scand
Abstract
Show
83
3
49
4
Get access via publisher
Add to collection
Cite
Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course
Kubiszewska
1
,
Szyluk
2
,
Szczudlik
3
et al.
2016
Brain and Behavior
Abstract
Show
52
7
41
1
Get access via publisher
Add to collection
Cite
1
2
3
4
5